Washington, DC-- This week's Journal of the American Medical Association (JAMA) contains new research findings about radiation therapy after surgery for prostate cancer. Lombardi Comprehensive Cancer Center Interim Director Anatoly Dritschilo, M.D., commented on the paper, released November 15:
"I would interpret this paper as a positive clinical trial in favor of post-operative radiation therapy for men with high risk findings following surgery. It is consistent with previously reported retrospective clinical trials, but carries more weight because it is a prospective and randomized study. Based on these findings, additional studies will be able to further refine patient selection in order to ensure patients receive the treatments that will be the most effective for them."
About Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 39 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.